Trials / Completed
CompletedNCT00259272
Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine
Phase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 141 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A non randomized study to validate the MATHYS Scale in a population of in and outpatients greater than or equal to 18 years of age, suffering from Bipolar Disorder I or II, and treated with olanzapine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olanzapine | 5 to 20 mg (flexible dose) administered orally as disintegrated tablets, daily for 24 weeks. |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2005-11-29
- Last updated
- 2009-06-24
- Results posted
- 2009-06-24
Locations
16 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00259272. Inclusion in this directory is not an endorsement.